Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

117772-70-0

Azithromycine 2H2O

117772-70-0
2482-00-0

Agmatine sulfate

2482-00-0
61336-70-7

Amoxicillin 3H2O

61336-70-7
7177-48-2

Ampicillin 3H2O

7177-48-2
34381-68-5

Acebutolol HCl

34381-68-5
103-90-2

Acetamidophenol-4

103-90-2
50-78-2

Acetylsalicylic acid

50-78-2
2827-56-7

Aminohydantoin-1 HCl

2827-56-7
50-81-7

Ascorbic acid

50-81-7
59-66-5

Acetazolamide

59-66-5
39831-55-5

Amikacine disulfate

39831-55-5
10439-39-1

Anthraquinone D8

10439-39-1
137-88-2

Amprolium HCl

137-88-2
55589-62-3

Acesulfam potassium

55589-62-3
139272-66-5

Aceclofenac Methyl Ester

139272-66-5
438-22-2

Androstan-5-alpha

438-22-2
89-65-6

Isoascorbic acid

89-65-6
139272-67-6

Aceclofenac Ethyl Ester

139272-67-6
59277-89-3

Acyclovir

59277-89-3
858956-08-8

Aminocyclopyrachlor

858956-08-8